The Prevalence of Irritable Bowel Syndrome Using Rome IV Criteria in Medical Student and The Related Factors
NCT ID: NCT03178877
Last Updated: 2017-06-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
350 participants
OBSERVATIONAL
2016-11-01
2016-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Prevalence and Risk Factors of Irritable Bowel Syndrome Among Adults
NCT05340400
The Expression of the Ionotropic Glutamate Receptors in Colon of IBS
NCT02512146
Prevalence of Irritable Bowel Syndrome in Medical Students Africa
NCT06097598
The Predictive Value of Alarm Symptoms in Patients With Irritable Bowel Syndrome Based on Rome IV
NCT03620994
Irritable Bowel Syndrome Survey in Gastroenterological Adult Outpatients in China
NCT02955316
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
ECOLOGIC_OR_COMMUNITY
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
IBS
IBS group is medical student who filled Rome IV criteria for IBS
No intervention
Non IBS
Non-IBS group is non IBS medical student based on Rome IV criteria
No intervention
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
No intervention
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Volunteer to participate in study
Exclusion Criteria
* Diagnosed as having Inflammatory bowel disease
* Peptic ulcer drug consumption
* History of gastrointestinal surgery
15 Years
30 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Indonesia University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ari Fahrial Syam
Medical Doctor, Gastroenterology Hepatology Consultant
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cipto Mangunkusumo Hospital
Jakarta Pusat, DKI Jakarta, Indonesia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
16-11-430
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.